9th - 10th September, Cambridge, UK
More informationJoin the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationThis guidance provides recommendations for sponsors, investigators, and other interested parties regarding the implementation of decentralised elements in clinical trials.
The Assembly of the International Council for Harmonisation (ICH) met in-person on 5 & 6 November 2024, in Montréal, Canada in parallel of meetings of 11 Working Groups and 1 Discussion Group, and preceded by meetings of the ICH Management Committee (MC) and the MedDRA MC.
This training material is comprised of a comprehensive presentation which addresses the implementation of the three guidelines, ICH Q8(R1), ICH Q9(R1) and ICH Q10, and how they work together.
Watch the MHRA webinar on Implementing the new UK Clinical Trials regulations, which took place on Tuesday 15 October 2024.
The MHRA is inviting members of the public to provide their views on proposed changes to the regulatory framework for medical devices.
The MHRA seeks views on pre-market regulations for medical devices to improve patient access and strengthen patient safety
Collaboration is always high on the agenda; RQA has several initiatives in the pipeline, with many more under discussion.
An at-a-glance summary of news from around the agency.
The Innovative Licensing and Access Pathway (ILAP) aims to get the most transformative new medicines to patients in the National Health Service (NHS) more quickly.
Latest CTIS newsletter released